ALPS Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,310
| Closed | -$529K | – | 1030 |
|
|
2024
Q3 | $529K | Sell |
33,310
-1,500
| -4% | -$23.8K | ﹤0.01% | 601 |
|
|
2024
Q2 | $530K | Buy |
34,810
+800
| +2% | +$12.2K | ﹤0.01% | 568 |
|
|
2024
Q1 | $499K | Sell |
34,010
-7,465
| -18% | -$110K | ﹤0.01% | 592 |
|
|
2023
Q4 | $577K | Sell |
41,475
-14,790
| -26% | -$206K | ﹤0.01% | 583 |
|
|
2023
Q3 | $752K | Sell |
56,265
-8,310
| -13% | -$111K | 0.01% | 536 |
|
|
2023
Q2 | $815K | Sell |
64,575
-2,510
| -4% | -$31.7K | 0.01% | 528 |
|
|
2023
Q1 | $764K | Buy |
67,085
+16,585
| +33% | +$189K | 0.01% | 519 |
|
|
2022
Q4 | $523K | Buy |
+50,500
| New | +$523K | ﹤0.01% | 581 |
|
|
2021
Q4 | – | Sell |
-39,860
| Closed | -$519K | – | 961 |
|
|
2021
Q3 | $519K | Buy |
39,860
+4,400
| +12% | +$57.3K | 0.01% | 494 |
|
|
2021
Q2 | $521K | Sell |
35,460
-2,765
| -7% | -$40.6K | ﹤0.01% | 511 |
|
|
2021
Q1 | $469K | Buy |
38,225
+5,525
| +17% | +$67.8K | ﹤0.01% | 493 |
|
|
2020
Q4 | $466K | Buy |
+32,700
| New | +$466K | 0.01% | 509 |
|
|
2019
Q4 | – | Sell |
-81,725
| Closed | -$619K | – | 852 |
|
|
2019
Q3 | $619K | Sell |
81,725
-2,995
| -4% | -$22.7K | ﹤0.01% | 455 |
|
|
2019
Q2 | $635K | Sell |
84,720
-1,425
| -2% | -$10.7K | ﹤0.01% | 484 |
|
|
2019
Q1 | $698K | Buy |
86,145
+4,455
| +5% | +$36.1K | ﹤0.01% | 411 |
|
|
2018
Q4 | $616K | Buy |
+81,690
| New | +$616K | ﹤0.01% | 432 |
|
|
2017
Q4 | – | Sell |
-142,380
| Closed | -$1.02M | – | 877 |
|
|
2017
Q3 | $1.02M | Buy |
142,380
+32,750
| +30% | +$234K | 0.01% | 239 |
|
|
2017
Q2 | $924K | Buy |
109,630
+45,085
| +70% | +$380K | 0.01% | 234 |
|
|
2017
Q1 | $518K | Buy |
64,545
+27,740
| +75% | +$223K | ﹤0.01% | 373 |
|
|
2016
Q4 | $333K | Buy |
36,805
+1,320
| +4% | +$11.9K | ﹤0.01% | 660 |
|
|
2016
Q3 | $329K | Buy |
35,485
+335
| +1% | +$3.11K | ﹤0.01% | 637 |
|
|
2016
Q2 | $360K | Buy |
35,150
+12,635
| +56% | +$129K | ﹤0.01% | 532 |
|
|
2016
Q1 | $203K | Buy |
+22,515
| New | +$203K | ﹤0.01% | 604 |
|